Advances on the influence of adipose tissue on prostate cancer

被引:2
作者
Lopez Fontana, Constanza [2 ]
Maselli Artola, M. Eugenia [2 ]
Vanrell Rodriguez, M. Cristina [2 ]
Di Milta Monaco, Nicolds A. [2 ]
Perez Elizalde, Rafael [2 ]
Lopez Laur, Jose D. [1 ]
机构
[1] Univ Nacl Cuyo, Fac Ciencias Med, Catedra Clin Urol, RA-5500 Mendoza, Argentina
[2] Univ Juan Agustin Maza, Fac Farm & Bioquim, Lab Enfermedades Metab & Canc, RA-5500 Mendoza, Argentina
来源
ACTAS UROLOGICAS ESPANOLAS | 2009年 / 33卷 / 03期
关键词
Adipose tissue; Adipokines; Obesity; Prostate cancer; BODY-MASS INDEX; TESTOSTERONE LEVELS; DIABETES-MELLITUS; OBESITY; ANDROGEN; LEPTIN; GROWTH; EXPRESSION; MEN; ADIPOCYTOKINES;
D O I
10.1016/S0210-4806(09)74137-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Numerous studies have investigated the association between obesity and prostate cancer (CaP), although the results have not been concluding due to the great difficulty to evaluate the effects of obesity on the development of this type of tumor. The aim of this study was to carry out a comprehensive over-view of the existing evidence about the role of adipose tissue in the prostate carcinogenesis. Recent evidence suggests that androgens. leptin. IL-6. VEGF. insulin and IGF-I may play a role in PC progression. while adiponectin and IGFBP-3 may act as "anti- prostatic cancer" adipokines. The potential mechanisms by which obesity may initiate, promote or facilitate the progression of CaP are low levels of testosterone and high levels of estrogen, coexisting metabolic syndrome, increased secretion of leptin. VEGF, IL-6 and TNF-alpha and decreased adiponectin, and excessive intake of saturated fat. Conclusion: Obesity may promote the progression of established PC rather than being a risk factor for the development of this tumour. However, additional studies are needed to clarify the relationship between adipokines and PC before developing new preventive or treatment. strategies for this tumor.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 49 条
[1]  
Abdollahi A, 2003, CANCER RES, V63, P8890
[2]   Relationship between obesity and prostate cancer [J].
Amling, CL .
CURRENT OPINION IN UROLOGY, 2005, 15 (03) :167-171
[3]  
Baillargeon J, 2006, INT J ONCOL, V28, P737
[4]  
Bain J, 2007, CLIN INTERV AGING, V2, P567
[5]   Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer [J].
Banez, Lionel L. ;
Hamilton, Robert J. ;
Partin, Alan W. ;
Vollmer, Robin T. ;
Sun, Leon ;
Rodriguez, Carmen ;
Wang, Yiting ;
Terris, Martha K. ;
Aronson, William J. ;
Presti, Joseph C., Jr. ;
Kane, Christopher J. ;
Amling, Christopher L. ;
Moul, Judd W. ;
Freedland, Stephen J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (19) :2275-2280
[6]   Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer [J].
Bouraoui, Yosra ;
Ricote, Monica ;
Garcia-Tunon, Ignacio ;
Rodriguez-Berriguete, Gonzalo ;
Touffehi, Mounir ;
Ben Rais, Nawfel ;
Fraile, Benito ;
Paniagua, Ricardo ;
Oueslati, Ridha ;
Royuela, Mar .
CANCER DETECTION AND PREVENTION, 2008, 32 (01) :23-32
[7]   Obesity and prostate cancer: Epidemiology and clinical implications [J].
Buschemeyer, W. Cooper, III ;
Freedland, Stephen J. .
EUROPEAN UROLOGY, 2007, 52 (02) :331-343
[8]   Interleukin-6 implication in prostate cancer [J].
Cabrespine, Aurelie ;
Bay, Jacques-Olivier ;
Verrelle, Pierre ;
Morel, Laurent .
BULLETIN DU CANCER, 2007, 94 :F29-F34
[9]   Role of diet in prostate cancer development and progression [J].
Chan, JM ;
Gann, PH ;
Giovannucci, EL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8152-8160
[10]   Interleukin-6 polymorphism: Expression and pleiotropic regulation in human prostate cancer [J].
Culig, Z .
JOURNAL OF UROLOGY, 2005, 174 (02) :417-417